Try

Corcept Therapeutics Incorporated Common Stock

CORTUnited States

78 filed reports · 393 financial concepts · 0 earnings calls · 0 media appearances

Filed reports

78 reports · Mar 2015 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 66 guidance figures.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR354,194Mar 2015 to Jun 2026
Current · 8-KSEC EDGAR3162Mar 2015 to Mar 2021
Annual · 10-KSEC EDGAR114,027Dec 2015 to Dec 2025
Annual · 10-K/ASEC EDGAR11Dec 2020

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Jul 29, 2026298Open
FY2026 Q110-QMar 31, 2026Apr 30, 2026177Open
FY202510-KDec 31, 2025Feb 24, 2026741Open
FY2025 Q310-QSep 30, 2025Nov 4, 2025207Open
FY2025 Q210-QJun 30, 2025Jul 31, 2025117Open
FY2025 Q110-QMar 31, 2025May 5, 2025135Open
FY202410-KDec 31, 2024Feb 26, 2025381Open
FY2024 Q310-QSep 30, 2024Oct 30, 2024155Open
FY2024 Q210-QJun 30, 2024Jul 29, 2024117Open
FY2024 Q110-QMar 31, 2024May 1, 2024121Open
FY202310-KDec 31, 2023Feb 15, 2024352Open
FY2023 Q310-QSep 30, 2023Nov 1, 2023139Open

Financial data

393 concepts · 8,284 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial391 concepts · 8,218 facts · Mar 2008 to Jul 2026

  • Cash and cash equivalents at carrying value65 · Dec 2012 to Jun 2026
  • Depreciation depletion and amortization63 · Dec 2013 to Jun 2026
  • Increase decrease in accounts payable63 · Dec 2013 to Jun 2026
  • Increase decrease in accounts receivable63 · Dec 2013 to Jun 2026
  • Increase decrease in inventories63 · Dec 2013 to Jun 2026
  • Increase decrease in prepaid deferred expense and other assets63 · Dec 2013 to Jun 2026
  • Net income loss63 · Dec 2013 to Jun 2026
  • Operating income loss63 · Dec 2013 to Jun 2026
  • Payments to acquire property plant and equipment63 · Dec 2013 to Jun 2026
  • Research and development expense63 · Dec 2013 to Jun 2026
  • Revenue63 · Dec 2013 to Jun 2026
  • Selling general and administrative expense63 · Dec 2013 to Jun 2026
  • Share based compensation63 · Dec 2013 to Jun 2026
  • Stockholders equity (US GAAP)63 · Dec 2012 to Jun 2026
  • Accounts payable current59 · Dec 2014 to Jun 2026
  • Accounts receivable net current59 · Dec 2014 to Jun 2026
  • Accrued liabilities current59 · Dec 2014 to Jun 2026
  • Accrued marketing costs current59 · Dec 2014 to Jun 2026
  • Assets59 · Dec 2014 to Jun 2026
  • Assets current59 · Dec 2014 to Jun 2026
  • Costs and expenses59 · Dec 2013 to Jun 2026
  • Inventory net59 · Dec 2014 to Jun 2026
  • Liabilities and stockholders equity59 · Dec 2014 to Jun 2026
  • Liabilities current59 · Dec 2014 to Jun 2026

Guidance1 concepts · 62 facts · May 2015 to May 2021

  • Revenue Guidance62 · May 2015 to May 2021

Product1 concepts · 4 facts · Jun 2025 to Jun 2026

  • Revenue4 · Jun 2025 to Jun 2026

Segments

4 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or service2 members · 4 facts

  • Hypercortisolism Products2 · Jun 2025 to Jun 2026
  • Lifyorli2 · Jun 2025 to Jun 2026

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary96 claims from 8 reports · Sep 2024 to Jun 2026
  • Management discussion (MD&A) commentary219 claims from 8 reports · Sep 2024 to Jun 2026
  • Risk-factor changes9 claims from 1 reports · Dec 2025
  • Risk factors51 risks from 2 annual reports · 2024 to 2025

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Corcept Therapeutics Incorporated Common Stock (CORT) data · FactIQ